Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] closed the trading session at $8.08. The stocks have a year to date performance of -29.37 percent and weekly performance of 6.32 percent. The stock has been moved at -12.36 percent over the last six months. The stock has performed
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] slipped around -0.05 points on Thursday, while shares priced at $7.60 at the close of the session, down -0.65%. Compared to the average trading volume of 4.66M shares, IRWD reached a trading volume of 3612849 in the most recent trading
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] traded at a high on Thursday, posting a 0.25 gain after which it closed the day’ session at $8.01. The results of the trading session contributed to over 2384262 shares changing hands. Over the past one week, the price volatility
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] surged by $0.05 during the normal trading session on while it closed the day at $9.02. The company report on February 29, 2024 at 6:00 AM that Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] slipped around -0.26 points on Tuesday, while shares priced at $8.69 at the close of the session, down -2.91%. The company report on February 29, 2024 at 6:00 AM that Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] closed the trading session at $9.43. The company report on February 29, 2024 at 6:00 AM that Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] traded at a high on Wednesday, posting a 1.64 gain after which it closed the day’ session at $15.45. The company report on February 1, 2024 at 4:01 PM that Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] stock went on an upward path that rose over 0.29% on Tuesday, amounting to a one-week price increase of more than 2.37%. The company report on January 8, 2024 at 7:00 PM that Ironwood Announces Publication in The Lancet Gastroenterology
© 2024, Powered by Smart TechOne
